MAPT and Alzheimer disease: The combination of p-tau/Aβ42 could also efficiently predict progression from MCI to AD with high efficiency (Hansson et al., 2006; Mattsson et al., 2009; Buchhave et al., 2012; Parnetti et al., 2012; Roe et al., 2013).